MESO
Price:
$14.87
Market Cap:
$1.95B
Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-mediated and inflammatory diseases. At the core of its innovation is a proprietary regenerative medicine platform utilizing specialized mesenchymal lineage cells. Currently, several of Mesoblast's leading product candidates are undergoing Phase III clinical trials: remestemcel-L, designed for severe, st...[Read more]
Industry
Biotechnology
IPO Date
2010-01-20
Stock Exchange
NASDAQ
Ticker
MESO
According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.03B. This represents a change of -0.68% compared to the average of 2.04B of the last 4 quarters.
The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 845.48M. The current 2.03B Enterprise Value has changed 23.91% with respect to the historical average. Over the past ten years (40 quarters), MESO's Enterprise Value was at its highest in in the December 2025 quarter at 2.35B. The Enterprise Value was at its lowest in in the December 2023 quarter at 221.98M.
Average
845.48M
Median
736.58M
Minimum
305.83M
Maximum
1.84B
Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.54%
Maximum Annual Enterprise Value = 1.84B
Minimum Annual Increase = -62.77%
Minimum Annual Enterprise Value = 305.83M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 1.84B | 51.29% |
| 2025 | 1.21B | 70.08% |
| 2024 | 713.46M | 23.70% |
| 2023 | 576.75M | 88.59% |
| 2022 | 305.83M | -62.77% |
| 2021 | 821.52M | -26.20% |
| 2020 | 1.11B | 107.54% |
| 2019 | 536.33M | -7.34% |
| 2018 | 578.82M | -23.81% |
| 2017 | 759.69M | 98.49% |
The current Enterprise Value of Mesoblast Limited (MESO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.25B
5-year avg
929.06M
10-year avg
845.48M
Mesoblast Limited’s Enterprise Value is greater than Ocular Therapeutix, Inc. (1.70B), less than Edgewise Therapeutics, Inc. (4.98B), greater than Galapagos N.V. (1.53B), greater than Structure Therapeutics Inc. (1.75B), less than uniQure N.V. (2.71B), less than Viridian Therapeutics, Inc. (2.56B), less than Liquidia Corporation (5.93B), less than Nuvation Bio Inc. (2.10B), less than ImmunityBio, Inc. (9.60B), less than Cogent Biosciences, Inc. (5.73B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.70B | $2.22B | |
| 4.98B | $5.05B | |
| 1.53B | $1.84B | |
| 1.75B | $2.02B | |
| 2.71B | $3.06B | |
| 2.56B | $2.48B | |
| 5.93B | $6.08B | |
| 2.10B | $2.11B | |
| 9.60B | $8.86B | |
| 5.73B | $5.67B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Mesoblast Limited's Enterprise Value?
What is the highest Enterprise Value for Mesoblast Limited (MESO)?
What is the 3-year average Enterprise Value for Mesoblast Limited (MESO)?
What is the 5-year average Enterprise Value for Mesoblast Limited (MESO)?
How does the current Enterprise Value for Mesoblast Limited (MESO) compare to its historical average?